Groton, MA, United States of America

Tom Wickham

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 10.0

ph-index = 3

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2019-2021

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Tom Wickham: Innovator in Therapeutic Solutions

Introduction

Tom Wickham is a prominent inventor based in Groton, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of novel therapeutic solutions. With a total of 5 patents, his work focuses on innovative approaches to cancer treatment and pharmaceutical applications.

Latest Patents

Wickham's latest patents include groundbreaking inventions such as functionalized erythroid cells. This patent describes novel preparations of functionalized erythroid cells and related compositions, reagents, and methods for use in human pharmaceutical and veterinary applications. Another significant patent involves compositions and methods related to multimodal therapeutic cancer indications. This invention includes therapies that provide and/or administer a plurality of agents functioning in a coordinated manner to deliver therapeutic benefits to subjects with cancer.

Career Highlights

Tom Wickham is currently associated with Rubius Therapeutics, Inc., where he continues to push the boundaries of innovation in therapeutic solutions. His expertise and dedication to research have positioned him as a key player in the biotechnology sector.

Collaborations

Wickham collaborates with talented professionals in his field, including Jordi Mata-Fink and Tiffany F. Chen. These partnerships enhance the development of innovative therapies and contribute to the advancement of medical science.

Conclusion

Tom Wickham's contributions to biotechnology and therapeutic innovations are noteworthy. His patents reflect a commitment to improving human health through advanced research and development. His work continues to inspire future innovations in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…